BECTON DICKINSON AND CO (BDX) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:BDX - US0758871091 - Common Stock
BDX Key Statistics, Chart & Performance
The current stock price of BDX is 193.96 USD. In the past month the price increased by 9.34%. In the past year, price decreased by -11.84%.
BDX Latest News, Press Relases and Analysis
BDX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.07 | 217.50B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.82 | 203.96B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.06 | 144.57B | ||
| SYK | STRYKER CORP | 27.64 | 139.21B | ||
| IDXX | IDEXX LABORATORIES INC | 56.63 | 57.02B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.54 | 50.02B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.62 | 38.93B | ||
| RMD | RESMED INC | 25.91 | 37.45B | ||
| DXCM | DEXCOM INC | 35.21 | 25.54B | ||
| PODD | INSULET CORP | 66.63 | 21.42B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.65 | 18.68B | ||
| HOLX | HOLOGIC INC | 17.56 | 16.71B |
Related stock screener links
About BDX
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417 US
CEO: Thomas E. Polen
Employees: 74000
Phone: 12018476800
BECTON DICKINSON AND CO / BDX FAQ
Can you describe the business of BECTON DICKINSON AND CO?
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Can you provide the latest stock price for BECTON DICKINSON AND CO?
The current stock price of BDX is 193.96 USD. The price increased by 0.1% in the last trading session.
Does BECTON DICKINSON AND CO pay dividends?
BECTON DICKINSON AND CO (BDX) has a dividend yield of 2.17%. The yearly dividend amount is currently 4.15.
What is the ChartMill rating of BECTON DICKINSON AND CO stock?
BDX has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
When is the next dividend date for BECTON DICKINSON AND CO (BDX)?
The next ex-dividend date for BECTON DICKINSON AND CO (BDX) is December 8, 2025.
Is BECTON DICKINSON AND CO (BDX) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BDX.
What is the employee count for BDX stock?
BECTON DICKINSON AND CO (BDX) currently has 74000 employees.
BDX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BDX. When comparing the yearly performance of all stocks, BDX is a bad performer in the overall market: 69.71% of all stocks are doing better.
BDX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BDX. BDX has an excellent profitability rating, but there are concerns on its financial health.
BDX Financial Highlights
Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 14.42. The EPS increased by 9.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.68% | ||
| ROA | 3.03% | ||
| ROE | 6.61% | ||
| Debt/Equity | 0.69 |
BDX Forecast & Estimates
19 analysts have analysed BDX and the average price target is 209.55 USD. This implies a price increase of 8.04% is expected in the next year compared to the current price of 193.96.
For the next year, analysts expect an EPS growth of 3.94% and a revenue growth 4.3% for BDX